Related Experiment Video

Updated: Aug 15, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart

Javier Díez1, Arantxa González, Begoña López

  • 1Division of Cardiovascular Pathophysiology, Center for Applied Medical Research, University of Navarra, Pamplona, and Division of Cardiology, Donostia University Hospital, San Sebastián, Spain. jadimar@unav.es

Nature Clinical Practice. Cardiovascular Medicine
|November 3, 2005
PubMed

Insights

Arterial hypertension causes cardiac fibrosis by disrupting collagen balance, increasing cardiac risk. This review explores mechanisms, consequences, diagnosis, and treatments for hypertensive ventricular fibrosis.

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Biochemistry

Background:

  • Arterial hypertension induces cardiac tissue changes, leading to myocardial structural remodeling.
  • This remodeling involves complex pathological processes in both cardiomyocyte and non-cardiomyocyte heart compartments.
  • A key process is the imbalance in collagen type I and III synthesis and degradation, causing excessive fibrosis.

Purpose of the Study:

  • To review the mechanisms driving hypertensive ventricular fibrosis.
  • To examine the clinical consequences of this fibrosis, particularly in hypertensive heart disease.
  • To discuss diagnostic methods and therapeutic strategies for reducing cardiac fibrosis.

Main Methods:

  • Review of existing literature on hypertensive cardiomyopathy and cardiac fibrosis.
  • Analysis of pathological pathways involving collagen metabolism.
  • Evaluation of diagnostic techniques and therapeutic interventions.

Main Results:

  • Hypertensive ventricular fibrosis results from disrupted collagen homeostasis.
  • This fibrosis is linked to increased cardiac risk in patients with hypertensive heart disease.
  • Noninvasive diagnostic methods and potential therapeutic targets are identified.

Conclusions:

  • Understanding the mechanisms of hypertensive fibrosis is crucial for managing cardiac risk.
  • Effective diagnosis and targeted therapies are needed to mitigate the effects of cardiac fibrosis.
  • Further research into therapeutic strategies can improve outcomes for patients with hypertensive heart disease.

More Related Videos

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...